Journal of Acute Care

Register      Login

VOLUME 1 , ISSUE 1 ( January-April, 2022 ) > List of Articles

View Point

Colloids should be Removed from the Intensive Care Unit Shelf

Keywords : Colloids, Crystalloids, Endothelium, Glycocalyx, Renal replacement therapy, Starling's equation

Citation Information : Colloids should be Removed from the Intensive Care Unit Shelf. 2022; 1 (1):20-22.

DOI: 10.5005/jp-journals-10089-0011

License: CC BY-NC 4.0

Published Online: 12-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Fluid therapy is one of the interventions in a day-to-day practice. It is predominantly used for resuscitating a patient with acute circulatory failure. Fluid therapy aims to improve macrocirculation and thereby oxygen delivery at the tissue level. Various fluids are available for resuscitating patients, classified into crystalloids or colloids. Still, we lack the ideal fluid for resuscitation. Colloids once promised to be the ideal fluid for resuscitation, their effectiveness has been questioned by the recent evidence and also indicated the possible harm associated with its use. Is there any truth in the matter?

  1. Evans L, Rhodes A, Alhazzani W, et al. Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021. Crit Care Med 2021;49(11):1974–1982. DOI: 10.1097/CCM.0000000000005357
  2. László I, Öveges N, Molnár Z. Distribution of crystalloids and colloids during fluid resuscitation: all fluids can be good and bad? In: Annual Update in Intensive Care and Emergency Medicine 2017. Springer, Cham; 2017. p. 91–103.
  3. Michel CC. Starling: the formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol 1997;82(1):1–30. DOI: 10.1113/expphysiol.1997.sp004000
  4. Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 2012;108(3):384–394. DOI: 10.1093/bja/aer515
  5. Johansson PI, Stensballe J, Ostrowski SR. Shock induced endotheliopathy (SHINE) in acute critical illness—a unifying pathophysiologic mechanism. Crit Care 2017;21(1):25. DOI: 10.1186/s13054-017-1605-5
  6. Milford EM, Reade MC. Resuscitation fluid choices to preserve the endothelial glycocalyx. Crit Care 2019;23(1):77. DOI: 10.1186/s13054-019-2369-x
  7. Lira A, Pinsky MR. Choices in fluid type and volume during resuscitation: impact on patient outcomes. Ann Intensive Care 2014;4:38. DOI: 10.1186/s13613-014-0038-4
  8. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350(22):2247–2256. DOI: 10.1056/nejmoa040232
  9. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358(2):125–139. DOI: 10.1016/s0084-3873(08)79064-3
  10. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367(20): 1901–1911. DOI: 10.1056/nejmx160007
  11. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367(2): 124–134. DOI: 10.1056/NEJMoa1204242
  12. Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014;370(15): 1412–1421. DOI: 10.1016/j.jemermed.2014.06.011
  13. Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011;364(26):2483–2495. DOI: 10.1056/nejmoa1101549
  14. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012;308(15):1566–1572. DOI: 10.1001/jama.2012.13356
  15. Young P, Bailey M, Beasley R, et al. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA 2015;314(16):1701–1710. DOI: 10.1001/jama.2015.12334
  16. Jo HA, Park S, Kim CD, et al. Efficacy and safety of a balanced salt solution versus a 0.9% saline infusion for the prevention of contrast-induced acute kidney injury (BASIC trial): a study protocol for a randomized controlled trial. Trials 2017;18(1):1–7. DOI: 10.1186/s13063-017-2202-2
  17. Hammond NE, Bellomo R, Gallagher M, et al. The Plasma-Lyte 148 v Saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality. Crit Care Resusc 2017;19(3):239–246. DOI: 10.1056/NEJMoa2114464
  18. Semler MW, Wanderer JP, Ehrenfeld JM, et al. Balanced crystalloids versus saline in the intensive care unit. The SALT randomized trial. Am J Respir Crit Care Med 2017;195(10):1362–1372. DOI: 10.1164/rccm.201607-1345OC
  19. Brown RM, Wang L, Coston TD, et al. Balanced crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med 2019;200(12):1487–1495. DOI: 10.1164/rccm.201903-0557OC
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.